Premium
Systemic therapy for advanced adrenal cancer
Author(s) -
Dreicer Robert
Publication year - 2012
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23078
Subject(s) - medicine , systemic therapy , mitotane , chemotherapy , neoplasm , adrenocortical carcinoma , cancer , systemic administration , oncology , pathology , breast cancer , microbiology and biotechnology , in vivo , biology
The systemic management of advanced adrenal cancer remains a major therapeutic dilemma as it is both highly resistant to systemic agents and very rare epithelial neoplasm making clinical investigation a significant challenge. The role of mitotane, systemic chemotherapy and novel targeted agents are reviewed. J. Surg. Oncol. 2012; 106:643–646. © 2012 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom